KCM
GILD icon

Kerusso Capital Management’s Gilead Sciences GILD Stock Holding History

Kerusso Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.69M Sell
40,822
-2,898
-7% -$406K 2.85% 4
2025
Q4 		$5.37M Buy
43,720
+10,421
+31% +$1.27M 2.48% 6
2025
Q3 		$3.7M Sell
33,299
-2,022
-6% -$230K 2.27% 14
2025
Q2 		$3.92M Buy
35,321
+17
+0% +$1.81K 2.42% 11
2025
Q1 		$3.96M Buy
35,304
+895
+3% +$92.3K 2.52% 8
2024
Q4 		$3.18M Buy
34,409
+76
+0.2% +$6.84K 2.03% 17
2024
Q3 		$2.88M Buy
34,333
+2,068
+6% +$158K 1.83% 26
2024
Q2 		$2.21M Buy
+32,265
New +$2.15M 1.61% 34

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Kerusso Capital Management's GILD Position: Q1 2026 in Review

Kerusso Capital Management reduced its Gilead Sciences (GILD) stake by 6.6% in Q1 2026, selling an estimated $406K and leaving 40,822 shares worth $5.69M. The position accounts for 2.85% of the portfolio, ranked #4.

Kerusso Capital Management first reported a position in GILD in Q2 2024 and has held it in 8 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Kerusso Capital Management held 40,822 shares of Gilead Sciences worth $5.69M as of Q1 2026.
  • Kerusso Capital Management sold 2,898 Gilead Sciences shares in Q1 2026, an estimated $406K.
  • Gilead Sciences made up 2.85% of Kerusso Capital Management's portfolio in Q1 2026, its #4 holding.
  • Kerusso Capital Management first reported a position in Gilead Sciences in Q2 2024 and has held it in 8 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Kerusso Capital Management's 13F filing for Q1 2026, filed 14 May 2026.